Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children’s nutritional products, and other nutritional products in Asia, Europe, Latin America, and North America. Its infant formula products include formulas for routine feeding; solutions formulas for mild intolerance and specialty formula products, including formulas for severe intolerance; formulas for premature and low birth weight infants; and medical nutrition products. The company also offers products for infants with milk protein allergy, gas/fussiness, lactose intolerance, anti-regurgitation, severe protein sensitivity, multiple food allergies, fat malabsorption, and premature infants, as well as soy formula. Its children’s nutrition products comprise nutritious powdered milk for picky eaters, nutritious powdered milk, and nutritious milk modifier. The company also offers a range of other products, including pre-natal and post-natal nutritional supplements for expectant and nursing mothers. Mead Johnson Nutrition Company markets its products under the Enfamil, Enfalac, Enfapro, Nutramigen, Pregestimil, Enfacare, Enfagrow, EnfaSchool, Enfakid, Sustagen KID, Lactum, Alacta, ChocoMilk, Cal-C-Tose, Expecta LIPIL, and EnfaMama names. It sells its products to retail channels, including mass merchandisers, club stores, grocery stores, drug stores, and convenience stores. The company was founded in 1905 and is headquartered in Glenview, Illinois. Mead Johnson Nutrition Company (NYSE: MJN), formerly a subsidiary of Bristol-Myers Squibb Co., completed its initial public offering in February 2009.

Key Statistics